DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Alembic Pharmaceuticals Limited — Analyst/Investor Meet Para A-XBRL

NSE 51 min ago·18 Sept 2026, 12:01 pm

Alembic Pharma

Alembic Pharmaceuticals Limited has announced that it will hold an analyst or institutional investor meeting. The company has informed the stock exchanges about this event, which is a routine procedure for publicly listed firms to communicate with market participants.

This announcement is primarily a procedural update for investors. It signals that the company is preparing to discuss its business performance, future strategy, or financial outlook with the investment community. For retail investors, it offers a chance to gain clarity on the company's direction through official channels.

Investors should wait for the company's official presentation or transcript after the meeting to understand the substance of the discussion. Until then, this news serves as a reminder to keep an eye on upcoming corporate disclosures for detailed insights.